{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:59:49Z","timestamp":1792007989589,"version":"4.4.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Gender dysphoria is characterized by a strong discomfort with the gender assigned at birth and the urge to live as a member of the opposite gender. The acquisition of phenotypic features of the desired gender requires the use of cross-sex hormones. Female-to-male (FtM) transsexual persons are treated with testosterone to induce virilization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The aim of the study was to assess the effects of three different testosterone formulations on body weight and composition and metabolic and bone parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Forty-five FtM transsexuals were randomly assigned to receive testoviron depot (i.m.: 100 mg\/10 days; n = 15), testosterone gel (50 mg\/die; n = 15), and testosterone undecanoate (i.m.: 1,000 mg every 6 weeks for the first 6 weeks and then every 12 weeks, n = 15). FtM individuals were studied before, at week 30, and at week 54 of testosterone treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Anthropometric, metabolic, bone, hematological, and biochemical parameters were evaluated at baseline and after 12 months of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Lean body mass significantly increased and fat mass decreased in all groups. No modifications were reported in fasting insulin and insulin sensitivity index. High-density plasma lipoprotein levels declined significantly and low-density lipoprotein concentrations increased significantly in the three groups. The activated partial thromboplastin time and factor I did not change while prothrombin time significantly increased in all groups. At week 54, all subjects were amenorrheic and time to amenorrhea did not differ between the three groups. Current general life satisfaction was increased in all subjects after 1 year of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>One-year testosterone administration in FtM transsexuals appears to be very safe with no differences among the testosterone formulations used. Our study is preliminary, and the detection of subtle or long-term differences in the effects of the three formulations may require further larger and longer term studies in this and other populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12698","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T10:44:29Z","timestamp":1411555469000},"page":"3002-3011","source":"Crossref","is-referenced-by-count":159,"title":["Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons"],"prefix":"10.1093","volume":"11","author":[{"given":"Carla","family":"Pelusi","sequence":"first","affiliation":[{"name":"Division of Endocrinology \u00a0 \u00a0 , Bologna , Italy"},{"name":"S. Orsola-Malpighi Hospital \u00a0 \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Costantino","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Physiopathology of Reproduction \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"Center for Protection of Sexual Health \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"S. Orsola-Malpighi Hospital \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 \u00a0 \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Martelli","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Physiopathology of Reproduction \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"Center for Protection of Sexual Health \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"S. Orsola-Malpighi Hospital \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 \u00a0 \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lambertini","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Physiopathology of Reproduction \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"Center for Protection of Sexual Health \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"S. Orsola-Malpighi Hospital \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 \u00a0 \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bazzocchi","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Radiology \u00a0 , Bologna , Italy"},{"name":"The \u201cRizzoli\u201d Institute \u00a0 , Bologna , Italy"},{"name":"Department of Specialized, Diagnostic, and Experimental Medicine, S. Orsola-Malpighi Hospital \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ponti","sequence":"additional","affiliation":[{"name":"Department of Specialized, Diagnostic, and Experimental Medicine, S. Orsola-Malpighi Hospital \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Battista","sequence":"additional","affiliation":[{"name":"Department of Specialized, Diagnostic, and Experimental Medicine, S. Orsola-Malpighi Hospital \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Venturoli","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Physiopathology of Reproduction \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"Center for Protection of Sexual Health \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"S. Orsola-Malpighi Hospital \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 \u00a0 \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Meriggiola","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Physiopathology of Reproduction \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"Center for Protection of Sexual Health \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"S. Orsola-Malpighi Hospital \u00a0 \u00a0 \u00a0 , Bologna , Italy"},{"name":"University of Bologna \u00a0 \u00a0 \u00a0 , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2024032602351794400_bib1","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: An Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351794400_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/EJE-09-1091","article-title":"Endocrine treatment of transsexual persons: An Endocrine Society Clinical Practice Guideline: Commentary from a European perspective","volume":"162","author":"Meriggiola","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024032602351794400_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Clinical practice. Care of transsexual persons","volume":"364","author":"Gooren","year":"2011","journal-title":"N Engl J Med"},{"key":"2024032602351794400_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.med.0000436187.95351.a9","article-title":"Safety of hormonal treatment in transgenders","volume":"20","author":"Meriggiola","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2024032602351794400_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/humupd\/dmh035","article-title":"Testosterone replacement therapy: Current trends and future directions","volume":"10","author":"Nieschlag","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2024032602351794400_bib6","first-page":"31","article-title":"Hormone treatment of the adult transsexual patient","volume":"64","author":"Gooren","year":"2005","journal-title":"Horm Res"},{"key":"2024032602351794400_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jc.2007-1809","article-title":"Long-term treatment of transsexuals with cross-sex hormones: Extensive personal experience","volume":"93","author":"Gooren","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351794400_bib8","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1111\/j.1743-6109.2010.01962.x","article-title":"Safety of physiological testosterone therapy in women: Lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy","volume":"7","author":"Traish","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2024032602351794400_bib10","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1743-6109.2008.00909.x","article-title":"Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals","volume":"5","author":"Meriggiola","year":"2008","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1743-6109.2007.00646.x","article-title":"Review of studies of androgen treatment of female-to-male transsexuals: Effects and risks of administration of androgens to females","volume":"5","author":"Gooren","year":"2008","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals","volume":"8","author":"Berra","year":"2006","journal-title":"Asian J Androl"},{"key":"2024032602351794400_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","article-title":"Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351794400_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1743-6109.2010.02200.x","article-title":"Update in testosterone therapy for men","volume":"8","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1745-7262.2007.00275.x","article-title":"More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate","volume":"9","author":"Saad","year":"2007","journal-title":"Asian J Androl"},{"key":"2024032602351794400_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9343(01)00833-6","article-title":"Intramuscular testosterone esters and plasma lipids in hypogonadal men: A meta-analysis","volume":"111","author":"Whitsel","year":"2001","journal-title":"Am J Med"},{"key":"2024032602351794400_bib17","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","article-title":"Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals","volume":"7","author":"Mueller","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602351794400_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2024032602351794400_bib20","article-title":"Advances in body composition assessment","volume-title":"Current issues in exercise science series (monograph 3)","author":"Lohman","year":"1992"},{"key":"2024032602351794400_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2605.2010.01122.x","article-title":"A placebo-controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: Effect on anthropometric, metabolic and biochemical parameters","volume":"34","author":"Pelusi","year":"2011","journal-title":"Int J Androl"},{"key":"2024032602351794400_bib22","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"JCEM"},{"key":"2024032602351794400_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2024032602351794400_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12570-012-0100-3","article-title":"The validation of the visual analogue scale for patient satisfaction after total hip arthroplasty","volume":"3","author":"Brokelman","year":"2012","journal-title":"Eur Orthop Traumatol"},{"key":"2024032602351794400_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1743-6109.2007.00556.x","article-title":"Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"4","author":"Jacobeit","year":"2007","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib26","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351794400_bib27","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1210\/jc.2007-0746","article-title":"Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals","volume":"92","author":"Mueller","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351794400_bib28","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1210\/jc.2012-1187","article-title":"Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy","volume":"97","author":"Van Caenegem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351794400_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men","volume":"1","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib30","first-page":"E317","article-title":"Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals","volume":"276","author":"Elbers","year":"1999","journal-title":"Am J Physiol"},{"key":"2024032602351794400_bib31","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.fertnstert.2010.03.048","article-title":"The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome","volume":"94","author":"Cupisti","year":"2010","journal-title":"Fertil Steril"},{"key":"2024032602351794400_bib32","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2010-0864","article-title":"Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis","volume":"95","author":"Bachman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602351794400_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.trsl.2011.06.003","article-title":"Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familiar thrombophilia","volume":"8","author":"Glueck","year":"2011","journal-title":"Transl Res"},{"key":"2024032602351794400_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1076029613499819","article-title":"Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: An exploratory, hypothesis-generating study","volume":"3","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"2024032602351794400_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1076029613485154","article-title":"Testosterone, thrombophilia, and thrombosis","volume":"1","author":"Glueck","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"2024032602351794400_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/0092623X.2012.736920","article-title":"A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery","volume":"39","author":"Costantino","year":"2013","journal-title":"J Sex Marital Ther"},{"key":"2024032602351794400_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2265.2009.03625.x","article-title":"Hormonal therapy and sex reassignment: A systematic review and meta-analysis of quality of life and psychosocial outcomes","volume":"72","author":"Murad","year":"2010","journal-title":"Clin Endocrinol"},{"key":"2024032602351794400_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jsm.12413","article-title":"Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria","volume":"11","author":"Fisher","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602351794400_bib39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/NMD.0000000000000046","article-title":"Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals","volume":"201","author":"Gorin-Lazard","year":"2013","journal-title":"J Nerv Ment Dis"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515306263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515306263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/12\/3002\/48358587\/jsm_11_12_3002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/12\/3002\/48358587\/jsm_11_12_3002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:56:14Z","timestamp":1711421774000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/11\/12\/3002\/6958026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12698","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,12]]},"published":{"date-parts":[[2014,12,1]]}}}